Author(s): Fang W, Piao Z, Buyse IM, Simon D, Sheu JC,
Abstract Share this page
Abstract The RIZ (PRDM2) locus commonly undergoes loss of heterozygosity (LOH) and maps within the minimal deleted region on 1p36 in hepatocellular carcinoma (HCC). Although peptide-altering mutations of RIZ are rare in HCC, the RIZ1 product is commonly lost in HCC and has tumour suppressive activities. Here, we analysed RIZ gene mutations and LOH in HCC, breast cancer, familial melanoma, colon cancer, and stomach cancer. We found 7 polymorphisms but no mutations. By analysing the Pro704-deletion polymorphism, we detected LOH of RIZ in 31 of 79 (39\%) informative HCC cases, 11 of 47 (23\%) colon cancer cases, 8 of 43 (19\%) breast cancer cases, 8 of 66 (12\%) stomach cancer cases. Importantly, loss of the Pro704(+)allele was found in 74\% of the 31 LOH positive HCC cases (P< 0.01), indicating a preferential loss and hence a stronger tumour suppressor role for this allele compared to the P704(-)allele. In addition, the Pro704(+)allele was found to be more common in Asians (0.61) than Caucasians (0.42) (P = 0.0000), suggesting an interesting link between gene polymorphisms and potential differences in tumour incidence between racial groups. Copyright 2001 Cancer Research Campaign.
This article was published in Br J Cancer
and referenced in Journal of Cancer Science & Therapy